Assignee
ELEVEN BIOTHERAPEUTICS INC
US·3 granted patents·4 pending applications·7 citations·filing 2012–2018
Top patents by PatentIndex Score
7 records- 0182US9951130B2IL-6 antagonists and uses thereofELEVEN BIOTHERAPEUTICS INC·Filed 2014·Granted Apr 24, 2018·7 cites·20 claims
- 0257US11459386B2IL-6 antagonists and uses thereofELEVEN BIOTHERAPEUTICS INC·Filed 2018·Granted Oct 4, 2022·0 cites·10 claims
- 0356US9458216B2Nucleic acid encoding chimeric IL-1 receptor type I antagonistsELEVEN BIOTHERAPEUTICS INC·Filed 2014·Granted Oct 4, 2016·0 cites·29 claims
- 0447US2014315817A1Variant serum albumin with improved half-life and other propertiesELEVEN BIOTHERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 0546US2016052993A1Albumin variants binding to fcrnELEVEN BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 0645US2014308239A1Chimeric cytokine formulations for ocular deliveryELEVEN BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 0732US2019046642A1Il-6 antagonist formulations and uses thereofELEVEN BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →